ID

18438

Description

Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00193505

Link

https://clinicaltrials.gov/show/NCT00193505

Keywords

  1. 11/4/16 11/4/16 -
Uploaded on

November 4, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-Hodgkins Lymphoma NCT00193505

Eligibility Non-Hodgkins Lymphoma NCT00193505

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
to be included in this study, you must meet the following criteria:
Description

Clinical Trial Eligibility Criteria Fulfill

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1550543
intermediate grade cd20-positive b-cell non-hodgkin's lymphoma
Description

Intermediate Grade B-Cell Non-Hodgkin's Lymphoma positive for CD20 antigen

Data type

boolean

Alias
UMLS CUI [1,1]
C1512858
UMLS CUI [1,2]
C0882818
persistent lymphoma after one or two previous chemotherapy regimens
Description

Chemotherapy Regimen Quantity | Lymphoma persistent

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C0024299
UMLS CUI [2,2]
C0205322
patients should not be considered candidates for high-dose chemotherapy
Description

Indication high-dose chemotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C1328050
ability to perform activities of daily living with assistance
Description

Ability to perform activities of everyday life Assisted

Data type

boolean

Alias
UMLS CUI [1,1]
C0562507
UMLS CUI [1,2]
C1269765
measurable or evaluable disease
Description

Measurable Disease | Evaluable Disease

Data type

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
age > 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
adequate bone marrow, liver and kidney function
Description

Bone Marrow function | Liver function | Renal function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
you cannot participate in this study if any of the following apply to you:
Description

Clinical Trial Eligibility Criteria Fulfill

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1550543
patients with impaired bone marrow reserve
Description

Few mature neutrophils in the bone marrow

Data type

boolean

Alias
UMLS CUI [1]
C2748959
female patients who are pregnant or lactating
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
serious active infection at the time of treatment
Description

Communicable Disease Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205404
any other serious underlying condition
Description

Comorbidity Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205404
brain or meningeal) with lymphoma
Description

Primary cerebral lymphoma | Meningeal Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0240803
UMLS CUI [2]
C2213017
hiv or aids-related lymphoma
Description

lymphoma; resulting from HIV disease | Lymphoma, AIDS-Related

Data type

boolean

Alias
UMLS CUI [1]
C1399703
UMLS CUI [2]
C0085090
received external beam radiation therapy to > 25% of active bone marrow.
Description

External Beam Radiation Therapy Bone Marrow Percentage

Data type

boolean

Alias
UMLS CUI [1,1]
C1517033
UMLS CUI [1,2]
C0005953
UMLS CUI [1,3]
C0439165
history of other cancers, either active or treated
Description

Malignant Neoplasms | Malignant Neoplasms Treated

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C1522326
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Description

Clinical Trial Eligibility Criteria Additional

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1524062

Similar models

Eligibility Non-Hodgkins Lymphoma NCT00193505

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Clinical Trial Eligibility Criteria Fulfill
Item
to be included in this study, you must meet the following criteria:
boolean
C1516637 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Intermediate Grade B-Cell Non-Hodgkin's Lymphoma positive for CD20 antigen
Item
intermediate grade cd20-positive b-cell non-hodgkin's lymphoma
boolean
C1512858 (UMLS CUI [1,1])
C0882818 (UMLS CUI [1,2])
Chemotherapy Regimen Quantity | Lymphoma persistent
Item
persistent lymphoma after one or two previous chemotherapy regimens
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0024299 (UMLS CUI [2,1])
C0205322 (UMLS CUI [2,2])
Indication high-dose chemotherapy
Item
patients should not be considered candidates for high-dose chemotherapy
boolean
C3146298 (UMLS CUI [1,1])
C1328050 (UMLS CUI [1,2])
Ability to perform activities of everyday life Assisted
Item
ability to perform activities of daily living with assistance
boolean
C0562507 (UMLS CUI [1,1])
C1269765 (UMLS CUI [1,2])
Measurable Disease | Evaluable Disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
Age
Item
age > 18 years
boolean
C0001779 (UMLS CUI [1])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, liver and kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Clinical Trial Eligibility Criteria Fulfill
Item
you cannot participate in this study if any of the following apply to you:
boolean
C1516637 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Few mature neutrophils in the bone marrow
Item
patients with impaired bone marrow reserve
boolean
C2748959 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
female patients who are pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Communicable Disease Serious
Item
serious active infection at the time of treatment
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Comorbidity Serious
Item
any other serious underlying condition
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Primary cerebral lymphoma | Meningeal Lymphoma
Item
brain or meningeal) with lymphoma
boolean
C0240803 (UMLS CUI [1])
C2213017 (UMLS CUI [2])
lymphoma; resulting from HIV disease | Lymphoma, AIDS-Related
Item
hiv or aids-related lymphoma
boolean
C1399703 (UMLS CUI [1])
C0085090 (UMLS CUI [2])
External Beam Radiation Therapy Bone Marrow Percentage
Item
received external beam radiation therapy to > 25% of active bone marrow.
boolean
C1517033 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
Malignant Neoplasms | Malignant Neoplasms Treated
Item
history of other cancers, either active or treated
boolean
C0006826 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
Clinical Trial Eligibility Criteria Additional
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial